DK174871B1 - Amphotericin-B/cholesterolsulfat-sammensætning og fremgangsmåde til fremstilling af samme - Google Patents
Amphotericin-B/cholesterolsulfat-sammensætning og fremgangsmåde til fremstilling af samme Download PDFInfo
- Publication number
- DK174871B1 DK174871B1 DK198805983A DK598388A DK174871B1 DK 174871 B1 DK174871 B1 DK 174871B1 DK 198805983 A DK198805983 A DK 198805983A DK 598388 A DK598388 A DK 598388A DK 174871 B1 DK174871 B1 DK 174871B1
- Authority
- DK
- Denmark
- Prior art keywords
- amb
- cholesterol
- amphotericin
- particles
- suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nanotechnology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/019,575 US4822777A (en) | 1987-02-27 | 1987-02-27 | Amphotericin B/cholesterol sulfate composition |
US1957587 | 1987-02-27 | ||
US8800599 | 1988-02-26 | ||
PCT/US1988/000599 WO1988006450A1 (fr) | 1987-02-27 | 1988-02-26 | Procede et composition de sulfate de cholesterol/amphotericine b |
Publications (3)
Publication Number | Publication Date |
---|---|
DK598388A DK598388A (da) | 1988-10-27 |
DK598388D0 DK598388D0 (da) | 1988-10-27 |
DK174871B1 true DK174871B1 (da) | 2004-01-12 |
Family
ID=21793937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198805983A DK174871B1 (da) | 1987-02-27 | 1988-10-27 | Amphotericin-B/cholesterolsulfat-sammensætning og fremgangsmåde til fremstilling af samme |
Country Status (12)
Country | Link |
---|---|
US (1) | US4822777A (fr) |
EP (1) | EP0303683B1 (fr) |
JP (1) | JPH0610134B2 (fr) |
AT (1) | ATE88348T1 (fr) |
AU (1) | AU599779B2 (fr) |
CA (1) | CA1336890C (fr) |
DE (1) | DE3880397T2 (fr) |
DK (1) | DK174871B1 (fr) |
FI (1) | FI884889A (fr) |
HK (1) | HK80596A (fr) |
NO (1) | NO884741L (fr) |
WO (1) | WO1988006450A1 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0825869B2 (ja) * | 1987-02-09 | 1996-03-13 | 株式会社ビタミン研究所 | 抗腫瘍剤包埋リポソ−ム製剤 |
US5032582A (en) * | 1987-02-27 | 1991-07-16 | Liposome Technology, Inc. | Method for treating fungal infections with amphotericin B/cholesterol sulfate composition |
US5616334A (en) * | 1987-03-05 | 1997-04-01 | The Liposome Company, Inc. | Low toxicity drug-lipid systems |
US6406713B1 (en) | 1987-03-05 | 2002-06-18 | The Liposome Company, Inc. | Methods of preparing low-toxicity drug-lipid complexes |
US5194266A (en) * | 1989-08-08 | 1993-03-16 | Liposome Technology, Inc. | Amphotericin B/cholesterol sulfate composition and method |
JP3074734B2 (ja) * | 1990-11-16 | 2000-08-07 | 日本新薬株式会社 | 分散製剤 |
EP0599977A1 (fr) * | 1991-08-14 | 1994-06-08 | SEQUUS PHARMACEUTICALS, INC. (a Delaware Corporation) | Procede de traitement contre le vih avec de l'amphotericine b a faible toxicite |
US5264220A (en) * | 1991-11-12 | 1993-11-23 | Long David M Jr | Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
WO1994008599A1 (fr) * | 1992-10-14 | 1994-04-28 | The Regents Of The University Of Colorado | Appariement d'ions de medicaments pour ameliorer l'efficacite et l'administration |
IT1283149B1 (it) * | 1996-07-12 | 1998-04-07 | Prodotti Antibiotici Spa | Complessi di n'-dimetilaminoacetilpartricina a dimetilaminoetilamide, o suoi sali, e colesterol 3-solfato |
US6613352B2 (en) | 1999-04-13 | 2003-09-02 | Universite De Montreal | Low-rigidity liposomal formulation |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
AU2002245181B2 (en) | 2000-12-21 | 2006-06-29 | Nektar Therapeutics | Pulmonary delivery of polyene antifungal agents |
TWI252847B (en) * | 2001-07-10 | 2006-04-11 | Synta Pharmaceuticals Corp | Synthesis of taxol enhancers |
TWI297335B (en) | 2001-07-10 | 2008-06-01 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
TWI332943B (en) * | 2001-07-10 | 2010-11-11 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
TWI330079B (en) * | 2003-01-15 | 2010-09-11 | Synta Pharmaceuticals Corp | Treatment for cancers |
TWI249408B (en) * | 2003-12-10 | 2006-02-21 | Ind Tech Res Inst | New antifungal formulation and manufacturing method thereof |
KR101313027B1 (ko) | 2004-06-23 | 2013-10-02 | 신타 파마슈티칼스 코프. | 암 치료용 비스(티오-히드라지드 아미드) 염 |
NZ562572A (en) * | 2005-04-15 | 2011-01-28 | Synta Pharmaceuticals Corp | Combination cancer therapy with BIS (thiohydrazide) amide compounds |
US7678832B2 (en) | 2005-08-16 | 2010-03-16 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amide) formulation |
WO2008024303A2 (fr) | 2006-08-21 | 2008-02-28 | Synta Pharmaceuticals Corp. | Composés servant à traiter des troubles prolifératifs |
WO2008027445A2 (fr) * | 2006-08-31 | 2008-03-06 | Synta Pharmaceuticals Corp. | Combinaisons de bis(thio-hydrazide amides) traitant le cancer |
US7645904B2 (en) * | 2006-09-15 | 2010-01-12 | Synta Pharmaceuticals Corp. | Purification of bis(thiohydrazide amides) |
US20100068251A1 (en) * | 2006-10-10 | 2010-03-18 | Jina Pharmaceuticals, Inc. | Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof |
DE102015102210A1 (de) | 2015-02-16 | 2016-08-18 | Heraeus Medical Gmbh | Antimykotischer polymerisierbarer Knochenzement und ein Verfahren zu seiner Herstellung |
CA3053566A1 (fr) * | 2017-02-21 | 2018-08-30 | Ico Therapeutics Inc. | Formulations orales solides d'amphotericine b |
CN110305926B (zh) * | 2019-05-27 | 2021-02-26 | 浙江工业大学 | 一种基于两性霉素b代谢途径的发酵方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4002741A (en) * | 1974-04-24 | 1977-01-11 | Valter Osvaldovich Kulbakh | Meglumine complex fungicidal polyene macrolide antibiotic compositions and treatment method |
US4468513A (en) * | 1980-09-22 | 1984-08-28 | Eli Lilly And Company | 2'-N-Acylated and 2'-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides |
PT78628B (en) * | 1984-05-02 | 1986-06-18 | Liposome Co Inc | Pharmaceutical composition with reduced toxicity |
US4707470A (en) * | 1985-05-17 | 1987-11-17 | Smithkline Beckman Corporation | Polyene antibiotic emulsion formulation |
-
1987
- 1987-02-27 US US07/019,575 patent/US4822777A/en not_active Expired - Lifetime
-
1988
- 1988-02-26 AT AT88902717T patent/ATE88348T1/de not_active IP Right Cessation
- 1988-02-26 WO PCT/US1988/000599 patent/WO1988006450A1/fr active IP Right Grant
- 1988-02-26 DE DE8888902717T patent/DE3880397T2/de not_active Expired - Fee Related
- 1988-02-26 AU AU14826/88A patent/AU599779B2/en not_active Ceased
- 1988-02-26 JP JP63502859A patent/JPH0610134B2/ja not_active Expired - Fee Related
- 1988-02-26 EP EP88902717A patent/EP0303683B1/fr not_active Expired - Lifetime
- 1988-02-29 CA CA000560142A patent/CA1336890C/fr not_active Expired - Fee Related
- 1988-10-21 FI FI884889A patent/FI884889A/fi not_active Application Discontinuation
- 1988-10-25 NO NO884741A patent/NO884741L/no unknown
- 1988-10-27 DK DK198805983A patent/DK174871B1/da not_active IP Right Cessation
-
1996
- 1996-05-09 HK HK80596A patent/HK80596A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US4822777A (en) | 1989-04-18 |
HK80596A (en) | 1996-05-17 |
JPH0610134B2 (ja) | 1994-02-09 |
NO884741D0 (no) | 1988-10-25 |
EP0303683A4 (fr) | 1989-12-28 |
ATE88348T1 (de) | 1993-05-15 |
DK598388A (da) | 1988-10-27 |
EP0303683A1 (fr) | 1989-02-22 |
FI884889A0 (fi) | 1988-10-21 |
JPH01502270A (ja) | 1989-08-10 |
DK598388D0 (da) | 1988-10-27 |
EP0303683B1 (fr) | 1993-04-21 |
FI884889A (fi) | 1988-10-21 |
NO884741L (no) | 1988-10-25 |
DE3880397D1 (de) | 1993-05-27 |
CA1336890C (fr) | 1995-09-05 |
AU599779B2 (en) | 1990-07-26 |
WO1988006450A1 (fr) | 1988-09-07 |
AU1482688A (en) | 1988-09-26 |
DE3880397T2 (de) | 1993-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK174871B1 (da) | Amphotericin-B/cholesterolsulfat-sammensætning og fremgangsmåde til fremstilling af samme | |
US5194266A (en) | Amphotericin B/cholesterol sulfate composition and method | |
US5032582A (en) | Method for treating fungal infections with amphotericin B/cholesterol sulfate composition | |
DK175201B1 (da) | Kompositioner omfattende antineoplastiske anthracyclinmidler indkapslet i micellulære phospholipidpartikler og fremgangsmåder til fremstilling deraf | |
US5077057A (en) | Preparation of liposome and lipid complex compositions | |
US5089181A (en) | Method of dehydrating vesicle preparations for long term storage | |
AU740111B2 (en) | Hyaluronic drug delivery system | |
JP3267611B2 (ja) | リポソーム−ポリエンプレリポソーム粉末とその製造方法 | |
EP0981332B1 (fr) | Composition pharmaceutique comprenant des liposomes lyophilises encapsulant un principe actif essentiellement insoluble dans l'eau, et procede de preparation de cette composition | |
Chandraprakash et al. | Pharmacokinetic evaluation of surfactant vesicle-entrapped methotrexate in tumor-bearing mice | |
AU775038B2 (en) | A liposome composition having resistance to freeze/thaw damage | |
AU638245B2 (en) | Preparation of liposome and lipid complex compositions | |
CN112137958A (zh) | 一种含阿霉素与免疫佐剂组合药物脂质体及其制备方法 | |
CN107320716B (zh) | 碱性成纤维细胞生长因子囊泡及其制备方法 | |
Machluf et al. | Characterization of microencapsulated liposome systems for the controlled delivery of liposome-associated macromolecules | |
Crommelin et al. | Physical stability on long-term storage | |
CA1321351C (fr) | Mode de deshydratation de preparations vesiculaires en vue d'un stockage de longue duree | |
Nounou et al. | Influence of different sugar cryoprotectants on the stability and physico-chemical characteristics of freeze-dried 5-fluorouracil plurilamellar vesicles | |
AU664857B2 (en) | HIV-treatment method with low-toxicity amphotericin B | |
CN108836944B (zh) | 一种大豆苷元长循环脂质体口服冻干制剂及其制备方法 | |
Soujanya et al. | A Review on Novel Vesicular Drug Delivery System: Proniosomes. | |
WO1992002208A1 (fr) | Composition de doxorubicine/liposome stable | |
Higgins et al. | A comparative investigation of glycinebetaine and dimethylsulphoxide as liposome cryoprotectants | |
Chena et al. | * corresponding author email address v. kett@ qub. ac. uk 7 | |
CN112773776A (zh) | 一种载药纳米粒体系 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |
Country of ref document: DK |